These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 3855472

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.
    Dorr RT, Alberts DS, Einspahr J, Mason-Liddil N, Soble M.
    Cancer Treat Rep; 1987 Mar; 71(3):267-72. PubMed ID: 3815394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
    Müller LJ, Moorer-van Delft CM, Zijl R, Roubos EW.
    Cancer Res; 1990 Mar 15; 50(6):1924-8. PubMed ID: 2407348
    [Abstract] [Full Text] [Related]

  • 7. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
    Rivera-Fillat MP, Pallarés-Trujillo J, Domènech C, Grau-Oliete MR.
    Br J Pharmacol; 1988 Apr 15; 93(4):902-8. PubMed ID: 3390658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds.
    Dorr RT, Alberts DS.
    Cancer Treat Rep; 1981 Apr 15; 65(11-12):1001-6. PubMed ID: 7296547
    [Abstract] [Full Text] [Related]

  • 10. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z, Ochs S.
    J Neurochem; 1980 Jan 15; 34(1):59-68. PubMed ID: 6161213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vindesine: a new vinca alkaloid.
    Bayssas M, Gouveia J, de Vassal F, Misset JL, Schwarzenberg L, Ribaud P, Musset M, Jasmin C, Hayat M, Mathé G.
    Recent Results Cancer Res; 1980 Jan 15; 74():91-7. PubMed ID: 7003662
    [Abstract] [Full Text] [Related]

  • 13. Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide.
    Dorr RT, Soble MJ, Liddil JD, Keller JH.
    J Clin Oncol; 1986 Sep 15; 4(9):1399-404. PubMed ID: 3091779
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo.
    Song S, Suzuki H, Terasaki T, Lemaire M, Sugiyama Y.
    J Pharmacol Exp Ther; 1998 Dec 15; 287(3):963-8. PubMed ID: 9864280
    [Abstract] [Full Text] [Related]

  • 15. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse.
    Dorr RT, Alberts DS.
    Cancer Treat Rep; 1983 May 15; 67(5):499-501. PubMed ID: 6850665
    [Abstract] [Full Text] [Related]

  • 16. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
    Hill BT, Whelan RD.
    J Natl Cancer Inst; 1981 Aug 15; 67(2):437-43. PubMed ID: 6943380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of vindesine and vincristine in humans.
    Owellen RJ, Root MA, Hains FO.
    Cancer Res; 1977 Aug 15; 37(8 Pt 1):2603-7. PubMed ID: 872088
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R.
    Cancer Chemother Pharmacol; 2005 Aug 15; 56(2):173-81. PubMed ID: 15824923
    [Abstract] [Full Text] [Related]

  • 20. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL, Sirotnak FM.
    Cancer Treat Rep; 1981 Aug 15; 65(11-12):1049-53. PubMed ID: 7296551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.